Key Record Dates Identifier: NCT02937285
Brief Title: National Multicenter, Controlled, Single-blind Study With Two Parallel Groups Evaluating the Safety and Efficacy of Sequential Treatment With Mitoxantrone and Interferon Versus Interferon Alone in Patients With Strong Risk of Progression in the Initial Phase of Multiple Sclerosis (MITOX-REBIF)

First Submitted : September 9, 2016
First Submitted that Met QC Criteria : October 14, 2016
First Posted : October 18, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : October 20, 2017
Last Update Posted : October 24, 2017